Details

Autor(en) / Beteiligte

• Price, Ashley M.
• Olson, Samantha M.
• Newhams, Margaret M.
• Halasa, Natasha B.
• Boom, Julie A.
• Sahni, Leila C.
• Pannaraj, Pia S.
• Irby, Katherine
• Bline, Katherine E.
• Maddux, Aline B.
• Nofziger, Ryan A.
• Cameron, Melissa A.
• Walker, Tracie C.
• Schwartz, Stephanie P.
• Mack, Elizabeth H.
• Smallcomb, Laura
• Schuster, Jennifer E.
• Hobbs, Charlotte V.
• Kamidani, Satoshi
• Tarquinio, Keiko M.
• Bradford, Tamara T.
• Levy, Emily R.
• Chiotos, Kathleen
• Bhumbra, Samina S.
• Cvijanovich, Natalie Z.
• Heidemann, Sabrina M.
• Cullimore, Melissa L.
• Gertz, Shira J.
• Coates, Bria M.
• Staat, Mary A.
• Zinter, Matt S.
• Kong, Michele
• Chatani, Brandon M.
• Hume, Janet R.
• Typpo, Katri V.
• Maamari, Mia
• Flori, Heidi R.
• Tenforde, Mark W.
• Zambrano, Laura D.
• Campbell, Angela P.
• Patel, Manish M.
• Randolph, Adrienne G.

Titel

BNT162b2 Protection against the Omicron Variant in Children and Adolescents

Ist Teil von

• The New England journal of medicine, 2022-05, Vol.386 (20), p.1899-1909

Ort / Verlag

United States: Massachusetts Medical Society

Erscheinungsjahr

2022

Link zum Volltext

Quelle

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

Beschreibungen/Notizen

• In this study evaluating BNT162b2, vaccine effectiveness against hospitalization for Covid-19 in the delta-predominant period among adolescents 12 to 18 years of age was more than 90%; during the omicron period, vaccine effectiveness was 40% against hospitalization and 79% against critical illness. Vaccine effectiveness against hospitalization was 68% among children 5 to 11 years of age.